Glenn Whaley's Net Worth
-$58 Thousand
Who is Glenn Whaley?
Glenn Whaley does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNIC, INC., and PERNIX THERAPEUTICS HOLDINGS, INC..
SEC CIK
Glenn Whaley's CIK is 0001724623
Past Insider Trading and Trends
2022 was Glenn Whaley's most active year for acquiring shares with 6 total transactions. Glenn Whaley's most active month to acquire stocks was the month of February. 2024 was Glenn Whaley's most active year for disposing of shares, totalling 7 transactions. Glenn Whaley's most active month to dispose stocks was the month of February. 2020 saw Glenn Whaley paying a total of $18,960.00 for 46,000 shares, this is the most they've acquired in one year. In 2018 Glenn Whaley cashed out on 84 shares for a total of $156.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNIC, INC. (IMUX) Snapshot price: $1.34
Chief Financial OfficerGlenn Whaley owns 25,510 units of Common Stock which is worth $34,183.40. From 2020 to 2024 Glenn Whaley acquired a total of 20,000 shares in IMMUNIC, INC. at a cost of $92,337.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +24.38% | 5K |
$1.75 | $8,750.00 | 25.51K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +32.24% | 5K |
$1.50 | $7,475.00 | 20.51K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +38.60% | 3.5K |
$3.05 | $10,657.50 | 12.57K |
Jun 3
| |||
Form 4
| +49.44% | 3K |
$5.08 | $15,240.00 | 9.07K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +75.00% | 1.5K |
$9.85 | $14,775.00 | 3.5K |
Aug 10
| |||
Form 4
| +100.00% | 1K |
$16.48 | $16,480.00 | 2K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 1K |
$18.96 | $18,960.00 | 1K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PERNIX THERAPEUTICS HOLDINGS, INC. No price found
VP Fin, PAO & ControllerGlenn Whaley owns 3,616 units of Common Stock. In the year 2017 Glenn Whaley acquired a total of 2,600 shares in PERNIX THERAPEUTICS HOLDINGS, INC., Glenn also disposed a total of 84 shares of PERNIX THERAPEUTICS HOLDINGS, INC. equalling to $156.24.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.27% | -84.00 |
$1.86 | -$156.24 | 3.62K |
Aug 8
| |||
Form 4
| +236.36% | 2.6K |
—
|
—
| 3.7K |
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||